These findings suggest that modification of the ubiquitin proteasome system may be beneficial in myosin storage myopathy by reducing the impact of MYH7 mutation in patients. The gene discussed is MYH7; the disease is congenital myopathy 7A, myosin storage, autosomal dominant.